A new review suggests that tirzepatide (Mounjaro, Zepbound) may have neuroprotective mechanisms that could help reduce the ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

The latecomer Manjaro is a dual-action agent that works with both GLP-1 and gastric inhibitory peptide (GIP), showing superior weight loss effects compared to Wegovy and currently leading in ...

NHS to monitor the mass rollout that will see around 220,000 people with the "greatest need" receive the weight loss jabs.

Rochelle McDonald has just been through the messiest of break-ups. “Guzman y Gomez were devastated,” she says, but 17 kilos ...

Intestinal motor activity and gastrointestinal plasma peptides (gastrin, gastric inhibitory peptide, neurotensin, and peptide YY) were measured serially on day 5 and between days 10 to 14 and 24 ...

The demise of danuglipron means that its clinical-stage obesity pipeline is now represented by PF-07976016, another oral drug that targets GLP-1 and gastric inhibitory peptide (GIPR) and is in ...

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain ...

Agerberth, B. et al. Isolation of three antibacterial peptides from pig intestine: gastric inhibitory polypeptide (7–42), diazepam-binding inhibitor (32–86) and a novel factor, peptide 3910.